141 related articles for article (PubMed ID: 30053015)
1. Failure pattern of elective nodal irradiation for esophageal squamous cell cancer treated with neoadjuvant chemoradiotherapy.
Zhou S; Zhang L; Luo L; Li Q; Shen J; Feng Z; Feng Y; Yang H; Liu M; Xi M
Jpn J Clin Oncol; 2018 Sep; 48(9):815-821. PubMed ID: 30053015
[TBL] [Abstract][Full Text] [Related]
2. Involved-Field Irradiation in Definitive Chemoradiotherapy for Locoregional Esophageal Squamous Cell Carcinoma: Results From the ESO-Shanghai 1 Trial.
Zhu H; Rivin Del Campo E; Ye J; Simone CB; Zhu Z; Zhao W; Amini A; Zhou J; Wu C; Tang H; Fan M; Li L; Lin Q; Xia Y; Li Y; Li J; Mo M; Jia H; Lu S; Wang J; Nie Y; Chen J; Wu S; Hamaji M; Haque W; Jeong BK; Shridhar R; Zhang Z; Chen Y; Zhao K
Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1396-1406. PubMed ID: 33677048
[TBL] [Abstract][Full Text] [Related]
3. Elective nodal irradiation or involved-field irradiation in definitive chemoradiotherapy for esophageal squamous cell cancer: a retrospective analysis in clinical N0 patients.
Sun Y; Zhang XL; Mao QF; Liu YH; Kong L; Li MH
Curr Oncol; 2018 Oct; 25(5):e423-e429. PubMed ID: 30464693
[TBL] [Abstract][Full Text] [Related]
4. Involved-field irradiation in definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma.
Zhang X; Li M; Meng X; Kong L; Zhang Y; Wei G; Zhang X; Shi F; Hu M; Zhang G; Yu J
Radiat Oncol; 2014 Feb; 9():64. PubMed ID: 24571804
[TBL] [Abstract][Full Text] [Related]
5. Failure patterns after adjuvant chemoradiotherapy following endoscopic resection for superficial esophageal squamous cell carcinoma.
Ikawa T; Ishihara R; Konishi K; Morimoto M; Hirata T; Kanayama N; Yamamoto S; Matsuura N; Wada K; Hayashi K; Ogawa K; Teshima T
Cancer Med; 2019 Aug; 8(10):4547-4554. PubMed ID: 31222974
[TBL] [Abstract][Full Text] [Related]
6. Elective nodal irradiation is not necessary in chemoradiotherapy for postoperative loco-regional recurrent esophageal cancer.
Jingu K; Umezawa R; Yamamoto T; Matsushita H; Ishikawa Y; Kozumi M; Kubozono M; Takahashi N; Kadoya N; Takeda K
Jpn J Clin Oncol; 2017 Mar; 47(3):200-205. PubMed ID: 28031356
[TBL] [Abstract][Full Text] [Related]
7. Elective nodal irradiation versus involved-field irradiation for stage II-IV cervical esophageal squamous cell carcinoma patients undergoing definitive concurrent chemoradiotherapy: a retrospective propensity study with 8-year survival outcomes.
Wang J; Wu Y; Zhang W; Chen Y; Liu Q; Jing S; Zhang J; Wu F; Wang J; Qiao X
Radiat Oncol; 2023 Aug; 18(1):142. PubMed ID: 37641149
[TBL] [Abstract][Full Text] [Related]
8. Elective nodal irradiation versus involved-field irradiation in patients with esophageal cancer receiving neoadjuvant chemoradiotherapy: a network meta-analysis.
Liu T; Ding S; Dang J; Wang H; Chen J; Li G
Radiat Oncol; 2019 Oct; 14(1):176. PubMed ID: 31619265
[TBL] [Abstract][Full Text] [Related]
9. Retrospective analysis of outcome differences in preoperative concurrent chemoradiation with or without elective nodal irradiation for esophageal squamous cell carcinoma.
Hsu FM; Lee JM; Huang PM; Lin CC; Hsu CH; Tsai YC; Lee YC; Chia-Hsien Cheng J
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e593-9. PubMed ID: 21658851
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome of concurrent chemoradiotherapy with elective nodal irradiation for inoperable esophageal cancer.
Jing Z; Chen T; Zhang X; Wu S
Cancer Sci; 2017 Sep; 108(9):1828-1833. PubMed ID: 28665042
[TBL] [Abstract][Full Text] [Related]
11. Involved-field irradiation concurrently combined with nedaplatin/5-fluorouracil for inoperable esophageal cancer on basis of (18)FDG-PET scans: a phase II study.
Yamashita H; Omori M; Takenaka R; Okuma K; Kobayashi R; Ohtomo K; Nakagawa K
Radiother Oncol; 2014 Nov; 113(2):182-7. PubMed ID: 25466372
[TBL] [Abstract][Full Text] [Related]
12. Recurrence patterns after neoadjuvant chemoradiotherapy compared with surgery alone in oesophageal squamous cell carcinoma: results from the multicenter phase III trial NEOCRTEC5010.
Liu S; Wen J; Yang H; Li Q; Chen Y; Zhu C; Fang W; Yu Z; Mao W; Xiang J; Han Y; Zhao L; Liu H; Hu Y; Liu M; Fu J; Xi M
Eur J Cancer; 2020 Oct; 138():113-121. PubMed ID: 32877795
[TBL] [Abstract][Full Text] [Related]
13. Elective nodal irradiation (ENI) in definitive chemoradiotherapy (CRT) for squamous cell carcinoma of the thoracic esophagus.
Onozawa M; Nihei K; Ishikura S; Minashi K; Yano T; Muto M; Ohtsu A; Ogino T
Radiother Oncol; 2009 Aug; 92(2):266-9. PubMed ID: 18952308
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant versus definitive chemoradiotherapy for locally advanced esophageal cancer : Outcomes and patterns of failure.
Haefner MF; Lang K; Verma V; Koerber SA; Uhlmann L; Debus J; Sterzing F
Strahlenther Onkol; 2018 Feb; 194(2):116-124. PubMed ID: 28916906
[TBL] [Abstract][Full Text] [Related]
15. Different recurrence pattern after neoadjuvant chemoradiotherapy compared to surgery alone in esophageal cancer patients.
Smit JK; Güler S; Beukema JC; Mul VE; Burgerhof JG; Hospers GA; Plukker JT
Ann Surg Oncol; 2013 Nov; 20(12):4008-15. PubMed ID: 23838922
[TBL] [Abstract][Full Text] [Related]
16. Involved-field chemoradiotherapy for postoperative solitary lymph node recurrence of esophageal cancer.
Kawamoto T; Nihei K; Sasai K; Karasawa K
Esophagus; 2018 Oct; 15(4):256-262. PubMed ID: 30225742
[TBL] [Abstract][Full Text] [Related]
17. Patterns of failure after involved field radiotherapy for locally advanced esophageal squamous cell carcinoma.
Li DJ; Li HW; He B; Wang GM; Cai HF; Duan SM; Liu JJ; Zhang YJ; Cui Z; Jiang H
J BUON; 2016; 21(5):1268-1273. PubMed ID: 27837632
[TBL] [Abstract][Full Text] [Related]
18. Oncologic Outcomes According to Remnant Lymph Node Metastases in Pathologic T0 (ypT0) Esophageal Squamous Cell Carcinoma Following Prospective Neoadjuvant Therapy and Surgery.
Cho HJ; Kim YH; Kim HR; Kim DK; Park SI; Kim JH; Kim SB
Ann Surg Oncol; 2015; 22(6):1851-7. PubMed ID: 25344308
[TBL] [Abstract][Full Text] [Related]
19. Trimodality therapy of esophagectomy plus neoadjuvant chemoradiotherapy improves the survival of clinical stage II/III esophageal squamous cell carcinoma patients.
Fujiwara Y; Yoshikawa R; Kamikonya N; Nakayama T; Kitani K; Tsujie M; Yukawa M; Inoue M; Yamamura T
Oncol Rep; 2012 Aug; 28(2):446-52. PubMed ID: 22664791
[TBL] [Abstract][Full Text] [Related]
20. Predictive value of nodal maximum standardized uptake value of pretreatment [18F]fluorodeoxyglucose positron emission tomography imaging in patients with esophageal cancer.
Yap WK; Chang YC; Tseng CK; Hsieh CH; Chao YK; Su PJ; Hou MM; Yang CK; Pai PC; Lin CR; Hsieh CE; Wu YY; Hung TM
Dis Esophagus; 2017 Aug; 30(8):1-10. PubMed ID: 28575243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
